Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Journal of the American Chemical Society|October 3, 2023
An Asymmetric Aromatic Finkelstein Reaction: A Platform for Remote Diarylmethane DesymmetrizationTobias Morack, Tyler E Myers, Lucas J Karas, et al.Journal of Cancer Research and Clinical Oncology|August 24, 2004
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II studyP Schmid, J Krocker, G Morack, et al.Nature Chemistry|July 17, 2025
Energy transfer-enabled enantioselective photocyclization using a privileged Al-salen catalystJulia Soika, Carina Onneken, Thorben Wiegmann, et al.Research in Human Development|March 19, 2016
Examining the Interplay of Processes Across Multiple Time-Scales: Illustration With the Intraindividual Study of Affect, Health, and Interpersonal Behavior (iSAHIB)Nilam Ram, David E Conroy, Aaron L Pincus, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II studyT Bauknecht, A Hefti, G Morack, et al.Zentralblatt Fur Gynakologie|January 1, 1990
[Effectiveness of cisplatin alone and in combination within the scope of primary therapy of ovarian cancer. Results of a prospective multicenter study]P Richter, W Krafft, U Müller, et al.Women'S Health Reports (New Rochelle, N.Y.)|May 1, 2025
High and Rapid Uptake of COVID-19 Vaccine Among Chicago Women with and Without HIVElizabeth Daubert, Mardge H Cohen, Tsion Yohannes, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trialJ-U Blohmer, P Schmid, J Hilfrich, et al.Brain and Behavior|August 7, 2023
Overnight urinary melatonin levels in women with and without HIV: An observational cohort studyHelen J Burgess, Kathleen M Weber, Ralph Morack, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2005
First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III studyO Feher, P Vodvarka, J Jassem, et al.Pageof 6